HUMASIS Co., Ltd.

As of June 30, 2026, HUMASIS Co., Ltd. carries a market capitalization of 52.16B, placing it among publicly traded companies globally. Its enterprise value stands at -77.07B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, HUMASIS Co., Ltd. has 22.63M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 1.64, and the price-to-book ratio stands at 0.25.

As of June 30, 2026, HUMASIS Co., Ltd. maintains a current ratio of 2.06, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 5.85, indicating elevated leverage, while an interest coverage ratio of -3.52 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, HUMASIS Co., Ltd. posted a negative return on equity (ROE) of -7.14, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -4.68, reflecting losses generated across the asset base. The company generates approximately 493.89M in revenue per employee across its workforce of 64.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 4.59 indicates how many times HUMASIS Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, HUMASIS Co., Ltd. recorded an income tax benefit of -1.16B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -27.73B and -15.61B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, HUMASIS Co., Ltd.'s stock has declined approximately 61.31% over the past 52 weeks. The 50-day moving average sits at 2,805.20, while the 200-day moving average is 3,584.68.

Over the twelve months ended June 30, 2026, HUMASIS Co., Ltd. generated 31.73B in revenue and converted that into -15.61B in net income, yielding earnings per share of -1,174.36. EBITDA reached -7.67B, while operating income came in at -14.20B.

As of June 30, 2026, HUMASIS Co., Ltd. holds 170.40B in cash and equivalents against 13.97B in total debt, resulting in a net debt position of -50.67B. Total book value stands at 211.59B, with working capital of 101.07B providing operational flexibility.

HUMASIS Co., Ltd. produced 12.65B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -2.01B in capital expenditures, free cash flow totaled 10.65B - equivalent to 470.48 per share.

Over the twelve months ended June 30, 2026, HUMASIS Co., Ltd. posted a gross margin of 10.71, reflecting its pricing power and cost economics. The operating margin of -44.76 and net profit margin of -49.19 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 20.41, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -20.86, meaning HUMASIS Co., Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

HUMASIS Co., Ltd.'s most recent stock split took place on May 11, 2026 with a 5:1 split ratio.

As of June 30, 2026, HUMASIS Co., Ltd. has an Altman Z-Score of 1.51, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.